Pharmaceutical

Innate Pharma plans IND of ADC candidate after positive preclinical data

Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.

Apr 11, 2024 - 00:00
Innate Pharma plans IND of ADC candidate after positive preclinical data
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.
Read the original article

Tags:

Previous Article

Pharmaceutical cleanrooms and cleanroom flooring suppliers

Next Article

Novartis plans to axe 680 employees

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharmaceutical Technology Excellence Awards 2024: SecureCHEK AI

Pharmaceutical Technology Excellence Awards 2024: Secur...

Jul 30, 2024

Johnson & Johnson sees highest patent filings and grants during August in Q3 2023

Johnson & Johnson sees highest patent filings and grant...

Nov 24, 2023

Physicians highlight need for improved non-opioid treatments for opioid use disorder

Physicians highlight need for improved non-opioid treat...

Sep 28, 2024